MAPT and Alzheimer disease: BBB dysfunction may also promote Alzheimer’s disease (AD) (Andjelkovic et al., 2023), with potential mechanisms including impaired perivascular clearance of amyloid-β and tau (Harrison et al., 2020), dysregulated cerebral blood flow or neurovascular coupling, or promoting a neuroinflammatory environment.